Invasive vulval cancer

Vulval cancer represents 5% of all gynaecological malignancies; with squamous cell carcinoma accounting for the vast majority. A noted rise in the incidence is attributed to a population of increasing age and exposure to aetiological factors among a younger population.If the disease is recognized at an early stage then treatment is likely to be curative, therefore it remains important to improve education and awareness among patients and primary care physicians in the recognition of early disease. Even with radical surgery, techniques are being developed to reduce the morbidity related to treatment and individualize patient care.The review discusses the aetiology, pathophysiology and management of a disease which carries long-term physical and psychological implications.